BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26316159)

  • 1. Next-generation sequencing: hype and hope for development of personalized radiation therapy?
    Tinhofer I; Niehr F; Konschak R; Liebs S; Munz M; Stenzinger A; Weichert W; Keilholz U; Budach V
    Radiat Oncol; 2015 Aug; 10():183. PubMed ID: 26316159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
    Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
    Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput sequencing in clinical oncology: from past to present.
    Mery B; Vallard A; Rowinski E; Magne N
    Swiss Med Wkly; 2019 Mar; 149():w20057. PubMed ID: 30946479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Applications of Next-Generation Sequencing.
    Rebollar-Vega RG; Arriaga-Canon C; de la Rosa-Velázquez IA
    Rev Invest Clin; 2018; 70(4):153-157. PubMed ID: 30067721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
    Furtado LV; Samowitz WS
    Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?
    Falk AT; Heeke S; Hofman V; Lespinet V; Ribeyre C; Bordone O; Poudenx M; Otto J; Garnier G; Castelnau O; Guigay J; Leroy S; Marquette CH; Hofman P; Ilié M
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):681-685. PubMed ID: 28511612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
    Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
    An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-free screening of single biomolecules through resistive pulse sensing technology for precision medicine applications.
    Harrer S; Kim SC; Schieber C; Kannam S; Gunn N; Moore S; Scott D; Bathgate R; Skafidas S; Wagner JM
    Nanotechnology; 2015 May; 26(18):182502. PubMed ID: 25875197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
    Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
    Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
    Bennett CW; Berchem G; Kim YJ; El-Khoury V
    Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
    Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
    Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Limitations, pitfalls and perspectives of diagnostic massive parallel sequencing efforts in oncology].
    Weichert W
    Pathologe; 2015 Nov; 36 Suppl 2():162-6. PubMed ID: 26391247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 17. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment.
    Roy S; LaFramboise WA; Nikiforov YE; Nikiforova MN; Routbort MJ; Pfeifer J; Nagarajan R; Carter AB; Pantanowitz L
    Arch Pathol Lab Med; 2016 Sep; 140(9):958-75. PubMed ID: 26901284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray and next-generation sequencing to analyse gastric cancer.
    Dang Y; Wang YC; Huang QJ
    Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.